Merck's oral antiviral could become the first FDA-authorized outpatient therapeutic that doesn't require a health care professional to administer.
Ivermectin, a pill used to treat parasites in humans, isn't approved for treating COVID-19, but that hasn't stopped some doctors from using it to combat the virus. However, a new outpatient oral treatment specifically designed to treat COVID-19 could be on the way.
"I'm cautiously optimistic," Dr. Andrew Bradley, head of the Mayo Clinic's Coronavirus Task Force, previously told."It's too early to say confident, but an effective oral antiviral would make treating COVID in the outpatient setting much easier."In a phase 3 clinical trial, researchers found molnupiravir reduced a person's risk of hospitalization or death by about 50 percent. About 7.
Both the World Health Organization and the FDA advise against the use of ivermectin to treat COVID-19.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Merck asks US FDA to authorize promising anti-COVID pillWASHINGTON (AP) — Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use weapon to the world's arsenal against the pandemic.
Lire la suite »
Merck seeks FDA emergency use authorization for antiviral Covid-19 treatment molnupiravirMerck said it is seeking FDA emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir.
Lire la suite »
Merck Asks FDA To Authorize Promising Anti-COVID PillAn antiviral pill that people could take at home to speed recovery could prove groundbreaking, easing the crushing caseload on U.S. hospitals.
Lire la suite »
Merck asks FDA for emergency authorization for experimental Covid pillIf cleared by the Food and Drug Administration — a decision that could come in a matter of weeks — it would be the first pill shown to treat Covid-19.
Lire la suite »
Merck asks FDA to authorize antiviral Covid pill for emergency useMerck has asked the FDA to authorize its antiviral Covid pill for emergency use. ScottGottliebMD weighs in: 'I think where the government misstepped is that we didn't invest enough in trying to scale up the manufacturing of therapeutics across the board.'
Lire la suite »